Lavers Jeffrey R
Known title: Group PresidentCIK: 0001820595
Associated companies
Transaction History
| MMM | ▲ Buy | Option Exercise | 570 | — | 10/4/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 570 | $50K | 10/4/2023 | View on chart |
| MMM | ▲ Buy | Option Exercise | 7,783 | $779K | 6/30/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 3,615 | $362K | 6/30/2023 | View on chart |
| MMM | ▲ Buy | Grant | 1,786 | $0 | 2/6/2023 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 854 | $0 | 2/6/2023 | View on chart |
| MMM | ▲ Buy | Grant | 787 | $0 | 2/7/2022 | View on chart |
| MMM | ▼ Sell | Tax Withholding | 388 | $0 | 2/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.